Medicenna Therapeutics Corp's market cap is currently C$65.93M. The company's EPS TTM is $-0.271; its P/E ratio is ―; Medicenna Therapeutics Corp is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -5.00K	C$ -5.00K	C$ -38.00K	C$ -40.00K	-
Operating Income	C$ -19.66M	C$ -21.64M	C$ -22.30M	C$ -17.19M	C$ -8.21M
EBITDA	C$ -18.67M	C$ -16.30M	C$ -22.54M	C$ -17.25M	C$ -8.27M
Net Income	C$ -25.47M	C$ 1.55M	C$ -22.65M	C$ -17.18M	C$ -8.31M
Balance Sheet
Cash & Short-Term Investments	C$ 16.98M	C$ 33.60M	C$ 20.54M	C$ 40.38M	C$ 37.70M
Total Assets	C$ 19.13M	C$ 36.45M	C$ 23.46M	C$ 42.25M	C$ 38.00M
Total Debt	C$ 0.00	C$ 0.00	C$ 0.00	C$ 34.00K	C$ 67.31K
Net Debt	C$ -16.98M	C$ -33.60M	C$ -20.54M	C$ -30.34M	C$ -22.63M
Total Liabilities	C$ 13.94M	C$ 6.96M	C$ 2.62M	C$ 4.11M	C$ 1.85M
Stockholders' Equity	C$ 5.19M	C$ 29.49M	C$ 20.84M	C$ 38.15M	C$ 36.15M
Cash Flow
Free Cash Flow	C$ -16.26M	C$ -12.66M	C$ -23.58M	C$ -15.31M	C$ -8.95M
Operating Cash Flow	C$ -16.26M	C$ -12.66M	C$ -23.58M	C$ -15.31M	C$ -8.95M
Investing Cash Flow	C$ 0.00	C$ -13.05M	C$ 10.05M	C$ 5.01M	C$ -15.00M
Financing Cash Flow	C$ 0.00	C$ 24.76M	C$ 3.88M	C$ 18.26M	C$ 44.28M

Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Income Statement >

Medicenna Therapeutics Corp Debt to Assets

Balance Sheet >

Medicenna Therapeutics Corp Cash Flow

Cash Flow >

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing